CN102831326A - Mean amplitude of glucose excursions (MAGE) calculation method - Google Patents

Mean amplitude of glucose excursions (MAGE) calculation method Download PDF

Info

Publication number
CN102831326A
CN102831326A CN2012103278556A CN201210327855A CN102831326A CN 102831326 A CN102831326 A CN 102831326A CN 2012103278556 A CN2012103278556 A CN 2012103278556A CN 201210327855 A CN201210327855 A CN 201210327855A CN 102831326 A CN102831326 A CN 102831326A
Authority
CN
China
Prior art keywords
blood sugar
blood glucose
value
data
calculation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012103278556A
Other languages
Chinese (zh)
Inventor
余学飞
李彬
简峻
彭达明
沈洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Medical University
Original Assignee
Southern Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Medical University filed Critical Southern Medical University
Priority to CN2012103278556A priority Critical patent/CN102831326A/en
Publication of CN102831326A publication Critical patent/CN102831326A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

本发明涉及一种平均血糖波动幅度的计算方法,该方法由以下步骤组成:读入从动态血糖监测仪器中获取的动态血糖监测数据,计算所获取的数据的血糖标准差;找出所获数据中所有的极值点,得到一极值点序列的集合,然后找出集合中相邻两极值点对应的血糖值差的绝对值不小于血糖标准差且相邻两极值点分别为极大值和极小值的有效极值点,再根据平均血糖波动幅度的计算公式,计算得到平均血糖波动幅度。该方法能够快速准确地分析动态血糖监测数据,获取有效的参数,在保证平均血糖波动幅度计算的准确性的同时,大大缩短了计算时间,提高了临床和科研工作的效率。

Figure 201210327855

The invention relates to a method for calculating the average blood sugar fluctuation range. The method is composed of the following steps: reading in the dynamic blood sugar monitoring data obtained from a dynamic blood sugar monitoring instrument, and calculating the blood sugar standard deviation of the obtained data; finding out the obtained data All the extreme points in , get a set of extreme point sequences, and then find out that the absolute value of the blood glucose difference corresponding to two adjacent extreme points in the set is not less than the standard deviation of blood glucose and the adjacent two extreme points are extreme The effective extremum point of the maximum value and the minimum value, and then calculate the average blood sugar fluctuation range according to the calculation formula of the average blood sugar fluctuation range. The method can quickly and accurately analyze the dynamic blood glucose monitoring data, obtain effective parameters, greatly shorten the calculation time while ensuring the accuracy of the average blood glucose fluctuation range calculation, and improve the efficiency of clinical and scientific research work.

Figure 201210327855

Description

一种平均血糖波动幅度的计算方法A Calculation Method of Average Blood Sugar Fluctuation Range

技术领域 technical field

本发明涉及体内血液特性的测量,具体涉及人体内平均血糖波动幅度参数的处理方法。The invention relates to the measurement of blood characteristics in the body, in particular to a processing method for parameters of the average blood sugar fluctuation range in the human body.

背景技术 Background technique

平均血糖波动幅度(Mean Amplitude of Glycemic Excursions,MAGE)是一种基于动态血糖监测数据建立的反应血糖波动的参考数值。目前的实际临床应用中,医务工作者让患者一次性佩戴监测仪器超过72小时来获取超过864个动态血糖监测数据,而MAGE数值往往不能直接从动态血糖监测系统中直接分析获得,仍必须通过人工筛选方式筛选动态血糖监测数据辅以分析系统进行计算,工作量较大。若获取的动态血糖监测数据增加时,计算工作量将大大增加,大大降低了临床诊断和科研的效率和参数的实效性。此外,为保证MAGE数值的准确性,进行筛选分析的医务工作者需要进行长时间的专业培训,若医务工作者的经验不足导致计算结果与真实值之间存在较大误差,也会降低了MAGE数值的准确性和有效性。Mean Amplitude of Glycemic Excursions (MAGE) is a reference value based on continuous blood glucose monitoring data to reflect blood glucose fluctuations. In the current actual clinical application, medical workers ask patients to wear the monitoring instrument for more than 72 hours at a time to obtain more than 864 continuous blood glucose monitoring data, and the MAGE value often cannot be directly analyzed and obtained from the continuous blood glucose monitoring system, and must still be obtained manually. Screening method Screening continuous blood glucose monitoring data supplemented by an analysis system for calculation, the workload is relatively large. If the acquired continuous blood glucose monitoring data increases, the calculation workload will be greatly increased, greatly reducing the efficiency of clinical diagnosis and scientific research and the effectiveness of parameters. In addition, in order to ensure the accuracy of MAGE values, medical workers who conduct screening analysis need to undergo long-term professional training. If the medical workers have insufficient experience, there will be a large error between the calculation results and the real value, which will also reduce the MAGE value. Accuracy and Validity of Values.

为了解决MAGE数值自动计算的问题,已有一些自动计算MAGE数值方法的报道,如,PeterA.Baghurst,”Calculating the Mean Amplitude of Glycemic Excursion from ContinuousGlucose Monitoring Data-An Automated Algorithm”,DiabetesTechnology&Therapeutics,vol.13,pp.296-302,2011和Gert Fritzsche,Klaus-DieterKohnert,Peter Heinke,Lutz Vogt,and Eckhard Salzsieder."The use of a computerprogram to calculate the Mean Amplitude of Glycemic Excursions",DiabetesTechnology&Therapeutics,vol.13,pp.319-325,2011。上述文献中,前者提供了一种基于自动识别动态血糖数据曲线中峰值和谷值点的计算方法,该方法由于对动态血糖数据曲线进行了平滑处理,容易导致数据失真,计算结果的准确性会受到影响,此外,该方法采用一阶差分方式识别曲线拐点,然而,动态血糖数据曲线中存在许多血糖值连续相等的数据,因此受到这些数据的影响,一阶差分方式识别曲线拐点也会导致计算误差;后者主要介绍了一种计算MAGE数值的计算分析程序,该文章的研究重点更多集中在计算的可行性和有效性评估,而对计算方法介绍较为简略。另外,这些报道中对于动态血糖监测数据中的有效血糖波动的判断仍然过分依赖肉眼观察和经验判断,因此仍然存在主观性的偏差。In order to solve the problem of automatic calculation of MAGE values, there have been some reports on automatic calculation of MAGE values, such as, PeterA. Baghurst, "Calculating the Mean Amplitude of Glycemic Excursion from Continuous Glucose Monitoring Data-An Automated Algorithm", Diabetes Technology & Therapeutics, vol.13, pp.296-302, 2011 and Gert Fritzsche, Klaus-Dieter Kohnert, Peter Heinke, Lutz Vogt, and Eckhard Salzsieder. "The use of a computer program to calculate the Mean Amplitude of Glycemic Excursions", Diabetes Technology, pp. 193 -325, 2011. In the above literature, the former provides a calculation method based on automatic identification of peak and valley points in the dynamic blood glucose data curve. This method is easy to cause data distortion due to the smoothing of the dynamic blood glucose data curve, and the accuracy of the calculation results will be affected. Affected, in addition, this method uses the first-order difference method to identify the inflection point of the curve. However, there are many data with continuous equal blood glucose values in the dynamic blood glucose data curve, so affected by these data, the first-order difference method to identify the inflection point of the curve will also lead to calculation Error; the latter mainly introduces a calculation and analysis program for calculating the MAGE value. The research focus of this article is more on the calculation feasibility and effectiveness evaluation, and the introduction to the calculation method is relatively brief. In addition, in these reports, the judgment of effective blood glucose fluctuations in continuous blood glucose monitoring data still relies too much on visual observation and empirical judgment, so there are still subjective biases.

发明内容 Contents of the invention

鉴于现有技术存在上述不足,本发明所要解决的技术问题是提供一种平均血糖波动幅度的计算方法,该方法可自动识别动态血糖监测数据中的有效血糖波动,快捷、准确地计算出平均血糖波动幅度。In view of the above deficiencies in the prior art, the technical problem to be solved by the present invention is to provide a method for calculating the average blood sugar fluctuation range, which can automatically identify the effective blood sugar fluctuations in the dynamic blood sugar monitoring data, and quickly and accurately calculate the average blood sugar volatility.

本发明解决上述问题的技术方案如下:The technical scheme that the present invention solves the above problems is as follows:

1.一种平均血糖波动幅度的计算方法,该方法包括以下步骤:1. A calculation method for the average blood sugar fluctuation range, the method comprising the following steps:

1)读入从动态血糖监测仪器中获取的动态血糖监测数据,计算所获取的数据的血糖标准差;计算所获数据中所有的极值点,得到一极值点序列的集合A;1) Read in the continuous blood glucose monitoring data obtained from the continuous blood glucose monitoring instrument, calculate the blood glucose standard deviation of the obtained data; calculate all the extreme points in the obtained data, and obtain a set A of extreme point sequences;

2)利用差分进化算法求解下式(1)所示的目标函数,统计集合A中符合以下两个条件的极值点,得到集合B:2) Use the differential evolution algorithm to solve the objective function shown in the following formula (1), count the extreme points in the set A that meet the following two conditions, and obtain the set B:

a.相邻的两个极值点对应的血糖值差的绝对值≥血糖标准差;a. The absolute value of the blood glucose value difference corresponding to two adjacent extreme points ≥ blood glucose standard deviation;

b.相邻的两个极值点一个是极大值,另一个是极小值;b. One of the two adjacent extreme points is a maximum value and the other is a minimum value;

argarg maxmax KK ,, nno 11 ,, nno 22 ,, .. .. .. ,, nno KK ZZ KK (( nno 11 ,, nno 22 ,, .. .. .. ,, nno KK )) == argarg maxmax KK ,, nno 11 ,, nno 22 ,, .. .. .. ,, nno KK ΣΣ kk == 11 KK -- 11 || ff (( tt nno kk ++ 11 )) -- ff (( tt nno kk )) || -- -- -- (( 11 ))

式(1)中,元素n1,n2,...,nk均为集合A中的元素,ZK(n1,n2,...,nk)为由元素n1,n2,...,nk所组成的子集{n1,n2,...,nk}对应的有效血糖波动的波动幅度之和,常数K为满足上述条件的极值点的个数,

Figure BDA00002104964000022
为子集{n1,n2,...,nk}中nk对应的血糖值;In formula (1), elements n 1 , n 2 ,...,n k are all elements in set A, and Z K (n 1 ,n 2 ,...,n k ) is composed of elements n 1 ,n 2 ,...,n k The subset {n 1 ,n 2 ,...,n k } corresponding to the sum of the effective blood sugar fluctuations, the constant K is the number of extreme points that meet the above conditions number,
Figure BDA00002104964000022
is the blood glucose value corresponding to n k in the subset {n 1 ,n 2 ,...,n k };

3)先计算集合B中各相邻极值点对应的血糖值差的绝对值,再计算所有绝对值的平均值,即得平均血糖波动幅度。3) First calculate the absolute value of the blood glucose value difference corresponding to each adjacent extreme point in set B, and then calculate the average value of all absolute values to obtain the average blood glucose fluctuation range.

为进一步保证最后计算的准确性,本发明在步骤1)中还包括数据预处理操作,具体过程为:In order to further ensure the accuracy of the final calculation, the present invention also includes a data preprocessing operation in step 1), the specific process is:

读入从动态血糖监测仪器中获取的动态血糖监测数据后,先删除血糖值相等的相邻两点中的后一血糖值数据,再计算所述的血糖标准差和所有的极值点。After reading in the continuous blood glucose monitoring data obtained from the continuous blood glucose monitoring instrument, first delete the next blood glucose value data among two adjacent points with equal blood glucose values, and then calculate the blood glucose standard deviation and all extreme points.

由于本发明采用差分进化算法求解无约束条件非线性规划问题目标函数,保证了有效血糖波动幅度的准确识别,避免了在计算过程中引入主观性因素影响,在保证计算准确性和一致性的同时,利用计算机辅助计算,大大提高了计算效率,具有较高的实效性。Since the present invention adopts differential evolution algorithm to solve the objective function of non-constrained nonlinear programming problem, it ensures the accurate identification of effective blood sugar fluctuation range, avoids the influence of subjectivity factors in the calculation process, and ensures the accuracy and consistency of calculation. , the use of computer-aided calculation greatly improves the calculation efficiency and has high effectiveness.

附图说明 Description of drawings

图1为本发明所述一种平均血糖波动幅度的计算方法的一个具体实施例的流程图。FIG. 1 is a flow chart of a specific embodiment of a method for calculating the average blood sugar fluctuation range of the present invention.

图2为一例就医者24小时动态血糖变化曲线图。Figure 2 is a 24-hour ambulatory blood glucose change curve of a patient seeking medical treatment.

图3为本发明所述一种平均血糖波动幅度的计算方法中滤除动态血糖监测数据曲线中的血糖值连续相等的数据段的示意图。Fig. 3 is a schematic diagram of filtering out data segments with consecutive equal blood glucose values in a dynamic blood glucose monitoring data curve in a method for calculating the average blood glucose fluctuation range according to the present invention.

图4为本发明所述一种平均血糖波动幅度的计算方法中求得所有有效极值点的后的数据曲线。Fig. 4 is a data curve after obtaining all effective extreme points in a method for calculating the average blood sugar fluctuation range according to the present invention.

图5为本发明所述一种平均血糖波动幅度的计算方法中所述的计算方法与传统人工计算方法对于不同数据分组的相关性分析结果。FIG. 5 is a correlation analysis result of different data groupings between the calculation method described in the present invention and the traditional manual calculation method.

图6为本发明所述一种平均血糖波动幅度的计算方法中所述的计算方法与传统人工计算方法对于不同组别数据的Bland-Altman评估图。Fig. 6 is a Bland-Altman evaluation chart of different groups of data between the calculation method described in the present invention and the traditional manual calculation method.

具体实施方式 Detailed ways

下面结合附图和实施例对本发明做进一步的详细描述。The present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments.

例1example 1

参见图1,以下以一例就医者24小时动态血糖变化曲线图为例详细描述本发明所述平均血糖波动幅度的计算方法:Referring to Fig. 1, the calculation method of the average blood sugar fluctuation range of the present invention will be described in detail by taking a 24-hour dynamic blood sugar change curve of a medical patient as an example:

1)从就医者所用的从动态血糖监测仪器中导出与图2相对应监测数据进行分析可知,血糖值为时间变量t的函数,可表示为f(t),且其中变量t为等时间间隔集合{t1,t2,...,tL}。如图2可见,曲线中存在许多如图中箭头所指的血糖值连续相等的数据段,即f(tx)=f(tx+1),其中x表示记录血糖值的序号。因此,为保证平均血糖波动幅度计算的准确性,需先去除血糖值相等的相邻两点中的后一血糖值数据,去除过程如图3所示。然后再计算处理后的数据的血糖标准差;利用离散序列极值点算法对处理后的数据进行求离散序列极值点操作,从而获得该数据的极值点序列的集合{1,2,...,N};1) From the analysis of monitoring data corresponding to Figure 2 derived from the continuous blood glucose monitoring instrument used by the doctor, it can be known that the blood glucose value is a function of the time variable t, which can be expressed as f(t), and the variable t is an equal time interval Set {t 1 ,t 2 ,...,t L }. It can be seen from Fig. 2 that there are many data segments in which the blood glucose values are continuously equal as indicated by the arrows in the graph, that is, f(t x )=f(t x+1 ), where x represents the serial number of the recorded blood glucose values. Therefore, in order to ensure the accuracy of the calculation of the average blood sugar fluctuation range, it is necessary to first remove the data of the next blood sugar value among two adjacent points with equal blood sugar values, and the removal process is shown in Figure 3 . Then calculate the blood glucose standard deviation of the processed data; use the discrete sequence extreme point algorithm to calculate the discrete sequence extreme point operation on the processed data, so as to obtain the set of extreme point sequences of the data {1,2,. ..,N};

2)以序列集合{1,2,...,N}作为搜索空间,利用差分进化算法求解目标函数的解,即求得所有有效极值点,具体步骤如下:2) Use the sequence set {1,2,...,N} as the search space, and use the differential evolution algorithm to solve the solution of the objective function, that is, to obtain all effective extreme points. The specific steps are as follows:

2.1)通常函数的极大值和极小值应交错出现,因此,当找出所有有效极值点时,血糖数据中有效血糖波动的波动幅度之和最大,用公式表示为:2.1) Normally, the maximum and minimum values of the function should appear alternately. Therefore, when all effective extreme points are found, the sum of the fluctuation ranges of the effective blood sugar fluctuations in the blood sugar data is the largest, expressed as:

argarg maxmax KK ,, nno 11 ,, nno 22 ,, .. .. .. ,, nno KK ZZ KK (( nno 11 ,, nno 22 ,, .. .. .. ,, nno KK )) == argarg maxmax KK ,, nno 11 ,, nno 22 ,, .. .. .. ,, nno KK ΣΣ kk == 11 KK -- 11 || ff (( tt nno kk ++ 11 )) -- ff (( tt nno kk )) || -- -- -- (( 11 ))

式(1)中,元素n1,n2,...,nk均为集合{1,2,...,N}中的元素,ZK(n1,n2,...,nk)为由元素n1,n2,...,nk所组成的子集{n1,n2,...,nk}对应的有效血糖波动的波动幅度之和,常数K为有效极值点的个数,

Figure BDA00002104964000032
为子集{n1,n2,...,nk}中nk对应的血糖值。子集{n1,n2,...,nk}满足条件:In formula (1), elements n 1 , n 2 ,...,n k are elements in the set {1,2,...,N}, Z K (n 1 ,n 2 ,..., n k ) is the sum of the fluctuation amplitudes of effective blood sugar fluctuations corresponding to the subset {n 1 , n 2 ,...,n k } composed of elements n 1 , n 2 ,...,n k , and the constant K is the number of effective extreme points,
Figure BDA00002104964000032
is the blood glucose value corresponding to n k in the subset {n 1 ,n 2 ,...,n k }. The subset {n 1 ,n 2 ,...,n k } satisfies the condition:

11 &le;&le; nno 11 << nno 22 << .. .. .. << nno KK &le;&le; NN (( -- 11 )) nno kk ++ 11 -- nno kk == -- 11 ,, kk == 1,21,2 ,, .. .. .. ,, KK -- 11 || ff (( tt nno kk ++ 11 )) -- ff (( tt nno kk )) || &GreaterEqual;&Greater Equal; SDSD ,, kk == 1,21,2 ,, .. .. .. ,, KK -- 11 -- -- -- (( 22 ))

式(2)中,SD为步骤1)中所述的血糖标准差,常数K为有效极值点的个数,2≤K≤N。In formula (2), SD is the standard deviation of blood glucose described in step 1), and the constant K is the number of effective extreme points, 2≤K≤N.

结合式(1)和式(2)可知,平均血糖波动幅度的计算即为以式(2)为约束条件对式(1)为目标函数的非线性规划问题的求解,若该问题对于常数K存在一个可行解

Figure BDA00002104964000041
和一个最大值
Figure BDA00002104964000042
那么,也一定存在一个对应于常数K-1的最大值
Figure BDA00002104964000043
若K*为该问题的可行解常数K的最大值,则可行解即为平均血糖波动幅度计算所需的所有有效极值点序列集合。Combining formula (1) and formula (2), it can be seen that the calculation of the average blood sugar fluctuation range is the solution of the nonlinear programming problem with formula (1) as the objective function with formula (2) as the constraint condition, if the problem is for the constant K there is a feasible solution
Figure BDA00002104964000041
and a maximum
Figure BDA00002104964000042
Then, there must also be a maximum value corresponding to the constant K-1
Figure BDA00002104964000043
and If K * is the maximum value of the feasible solution constant K of the problem, then the feasible solution That is, the set of all effective extreme point sequences required for the calculation of the average blood sugar fluctuation range.

2.2)利用差分进化算法求解通过对求解步骤2.1)所得有约束条件的非线性规划问题目标函数,从而得到可行解

Figure BDA00002104964000046
具体步骤为:2.2) Use the differential evolution algorithm to solve the objective function of the nonlinear programming problem with constraints obtained in the solution step 2.1), so as to obtain a feasible solution
Figure BDA00002104964000046
The specific steps are:

2.2.1)利用惩罚函数算法,令式(3)为惩罚函数并初始化惩罚系数,结合式(2)将式(1)转化为无约束条件的非线性规划问题目标函数:2.2.1) Using the penalty function algorithm, let formula (3) be the penalty function and initialize the penalty coefficient, and combine formula (2) to transform formula (1) into an unconstrained nonlinear programming problem objective function:

gg kk (( nno 11 ,, nno 22 ,, .. .. .. ,, nno KK )) -- SDSD -- || ff nno kk ++ 11 -- ff nno kk || hh kk (( nno 11 ,, nno 22 ,, .. .. .. ,, nno KK )) == (( -- 11 )) nno KK ++ 11 -- nno kk ++ 11 ,, kk == 1,21,2 ,, .. .. .. ,, KK -- 11 -- -- -- (( 33 ))

argarg minmin nno 11 ,, nno 22 ,, .. .. .. ,, nno KK YY KK (( nno 11 ,, nno 22 ,, .. .. .. ,, nno KK ))

== argarg minmin KK ,, nno 11 ,, nno 22 ,, .. .. .. ,, nno KK [[ -- &Sigma;&Sigma; kk == 11 KK -- 11 || ff nno kk ++ 11 -- ff nno kk || ++ &Sigma;&Sigma; kk == 11 KK -- 11 &mu;&mu; kk maxmax {{ 00 ,, gg kk }} 22 ++ &Sigma;&Sigma; kk == 11 KK -- 11 &lambda;&lambda; kk hh kk 22 ]] -- -- -- (( 44 ))

式(4)中,μk和λk为惩罚系数,且均趋向于+∞,由式(4)可知,当式(4)的最小值YK *>0时,该无约束条件的非线性规划问题目标函数无可行解。In formula (4), μ k and λ k are penalty coefficients, and they both tend to +∞. It can be seen from formula (4) that when the minimum value Y K * of formula (4) > 0, the unconstrained The objective function of the linear programming problem has no feasible solution.

2.2.2)利用差分进化算法求解步骤2.2.1)所得无约束条件非线性规划问题目标函数:2.2.2) Use the differential evolution algorithm to solve the objective function of the unconstrained nonlinear programming problem obtained in step 2.2.1):

2.2.2A)初始化差分进化算法中所涉及的参数:包括种群数量NP、最大迭代次数Gmax以及迭代计数器G=1、解空间最大维度N、交叉概率CR;2.2.2A) Initialize the parameters involved in the differential evolution algorithm: including the population size NP, the maximum number of iterations G max and the iteration counter G=1, the maximum dimension N of the solution space, and the crossover probability CR;

2.2.2B)随机创建一个初始化种群并将该种群均匀分布于整个解的搜索空间,种群的表示形式如下式:2.2.2B) Randomly create an initialization population and evenly distribute the population in the search space of the entire solution. The representation of the population is as follows:

NN ii 00 == (( 1,11,1 ,, .. .. .. ,, 11 )) ++ NINTNINT [[ (( &rho;&rho; ii 11 ,, &rho;&rho; ii 22 ,, .. .. .. ,, &rho;&rho; iNi )) &CenterDot;&Center Dot; (( NN -- 11 )) ]] -- -- -- (( 55 ))

式(5)中,i为当前试验向量的索引,为目标向量,ρi1为[0,1]间的随机数,NINT[B]表示对向量B做四舍五入取整操作;In formula (5), i is the index of the current test vector, is the target vector, ρ i1 is a random number between [0,1], and NINT[B] means rounding and rounding the vector B;

2.2.2C)从K=2维搜索空间开始,搜索整个搜索空间,直至可行解的搜索空间大小等于极值点的集合大小,具体步骤为:2.2.2C) Starting from the K=2-dimensional search space, search the entire search space until the size of the search space of the feasible solution is equal to the size of the set of extreme points. The specific steps are:

2.2.2D)在当前代中搜索目标函数的可行解,对于每一代G的目标向量在同一代中随机抽取其他三个不同的个体向量

Figure BDA00002104964000052
Figure BDA00002104964000053
其中r2,r2,r2是在[1,NP]区间中随机抽取、互不相等的三个整数,且均与当前试验向量的索引i不相等。那么通过差分策略得到一个与之对应的变异向量
Figure BDA00002104964000054
2.2.2D) Search for a feasible solution of the objective function in the current generation, for the objective vector of each generation G Randomly sample other three different individual vectors in the same generation
Figure BDA00002104964000052
and
Figure BDA00002104964000053
Among them, r 2 , r 2 , and r 2 are three unequal integers randomly selected in the [1,NP] interval, and all of them are unequal to the index i of the current test vector. Then get a corresponding mutation vector through the difference strategy
Figure BDA00002104964000054

VV ii GG == NN rr 11 GG ++ NINTNINT [[ Ff &times;&times; (( NN rr 22 GG -- NN rr 33 GG )) ]] -- -- -- (( 66 ))

式(6)中,F为一个[0,1]区间内取值的差分向量缩放因子;In formula (6), F is a difference vector scaling factor with a value in the interval [0,1];

2.2.2E)在步骤2.2.2D)所得到的变异向量

Figure BDA00002104964000056
和对应的目标向量
Figure BDA00002104964000057
间进行交叉操作生成一个试验向量
Figure BDA00002104964000058
2.2.2E) The mutation vector obtained in step 2.2.2D)
Figure BDA00002104964000056
and the corresponding target vector
Figure BDA00002104964000057
A test vector
Figure BDA00002104964000058

uu jithe ji GG == vv jithe ji GG ,, randrand [[ 0,10,1 ]] &le;&le; CRorjCRorj == jj randrand ,, nno jithe ji GG ,, otherwiseotherwise ,, jj == 1,21,2 ,, .. .. .. ,, nno .. -- -- -- (( 77 ))

式(7)中CR∈[0,1]是一个由差分进化法使用者所设定的交叉概率,jrand是在[1,NP]区间内随机选择的索引,该索引用于保证

Figure BDA000021049640000510
能在
Figure BDA000021049640000511
中至少获得一个参数值。目标向量的整数参数按照从小到大顺序进行排列;In formula (7), CR∈[0,1] is a crossover probability set by the user of the differential evolution method, and j rand is an index randomly selected in the interval [1,NP], which is used to ensure
Figure BDA000021049640000510
can be in
Figure BDA000021049640000511
Get at least one parameter value in . target vector The integer parameters of are arranged in ascending order;

2.2.2F)采用贪婪搜索策略对步骤2.2.2E)所得到的试验向量

Figure BDA000021049640000513
与目标向量
Figure BDA000021049640000514
进行比较选择,若试验向量
Figure BDA000021049640000515
所决定的函数值
Figure BDA000021049640000516
小于目标向量所决定的函数值
Figure BDA000021049640000518
则下一代的目标向量由当前代的试验向量取代,如否,则将当前带的目标向量保留至下一代,用公式(8)表示如下:2.2.2F) Apply the greedy search strategy to the test vector obtained in step 2.2.2E)
Figure BDA000021049640000513
with the target vector
Figure BDA000021049640000514
For comparison selection, if the test vector
Figure BDA000021049640000515
The determined function value
Figure BDA000021049640000516
less than target vector The determined function value
Figure BDA000021049640000518
Then the target vector of the next generation is replaced by the test vector of the current generation, if not, the target vector of the current band is retained to the next generation, expressed as follows by formula (8):

NN ii GG ++ 11 == Uu ii GG ,, ifYifY (( Uu ii GG )) << YY (( NN ii GG )) ,, NN ii GG ,, otherwiseotherwise .. -- -- -- (( 88 )) ;;

2.2.2G)令迭代计数器递增1,若当前迭代计数器数值G小于最大迭代次数Gmax,则重复步骤2.2.2D)、2.2.2E)、2.2.2F),在下一代中搜索可行解,若当前迭代计数器数值G等于最大迭代次数Gmax,则跳出迭代并计算所有有效血糖波动的波动幅度之和的最大值

Figure BDA000021049640000520
Figure BDA000021049640000521
不大于0,则令解空间维度递增1,并重复步骤2.2.2D)、2.2.2E)、2.2.2F),若
Figure BDA000021049640000522
大于0,则差分进化计算结束,此时的即为有约束条件非线性规划问题目标函数的最大值,对应的解即为有约束条件非线性规划问题目标函数的可行解
Figure BDA00002104964000061
即求得所有有效极值点序列集合,如图4所示;2.2.2G) Increase the iteration counter by 1, if the current iteration counter value G is less than the maximum number of iterations G max , then repeat steps 2.2.2D), 2.2.2E), 2.2.2F), and search for a feasible solution in the next generation, if The current iteration counter value G is equal to the maximum number of iterations G max , then jump out of the iteration and calculate the maximum value of the sum of the fluctuation ranges of all valid blood sugar fluctuations
Figure BDA000021049640000520
like
Figure BDA000021049640000521
is not greater than 0, increase the solution space dimension by 1, and repeat steps 2.2.2D), 2.2.2E), 2.2.2F), if
Figure BDA000021049640000522
is greater than 0, the differential evolution calculation ends, and at this time That is, the maximum value of the objective function of the nonlinear programming problem with constraints, and the corresponding solution is the feasible solution of the objective function of the nonlinear programming problem with constraints
Figure BDA00002104964000061
That is to obtain all effective extremum point sequence sets, as shown in Figure 4;

3)根据步骤2.2.2G)所有有效极值点序列集合,计算平均血糖波动幅度,计算过程如下:3) Calculate the average blood sugar fluctuation range according to step 2.2.2G) of all valid extremum point sequences, and the calculation process is as follows:

a)若

Figure BDA00002104964000062
对应的是动态血糖监测数据的第一个局部极小值点,则平均血糖波动幅度的计算公式为:a) if
Figure BDA00002104964000062
Corresponding to the first local minimum point of the continuous blood glucose monitoring data, the calculation formula of the average blood glucose fluctuation range is:

b)若

Figure BDA00002104964000064
对应的是动态血糖监测数据的第一个局部极大值点,则平均血糖波动幅度的计算公式为:b) if
Figure BDA00002104964000064
Corresponding to the first local maximum point of the continuous blood glucose monitoring data, the calculation formula of the average blood glucose fluctuation range is:

Figure BDA00002104964000065
Figure BDA00002104964000065

式(9)和式(10)中,MAGE+为以第一个有效波动方向(从波谷到波峰或从波峰到波谷)为计算方向的平均血糖波动幅度,MAGE-为以该计算方向的另一侧(从波峰到波谷或从波谷到波峰)为计算方向的平均血糖波动幅度,MAGEa是MAGE+和MAGE-的平均值。In formulas (9) and (10), MAGE + is the average blood sugar fluctuation range based on the first effective fluctuation direction (from trough to peak or from peak to trough) as the calculation direction, and MAGE - is the other calculation direction based on this calculation direction. One side (peak to trough or trough to peak) is the mean magnitude of blood glucose fluctuation in the calculated direction, and MAGE a is the average of MAGE + and MAGE- .

例2(方法的准确性和和可行性验证)Example 2 (method accuracy and feasibility verification)

下表1所示为从76例就医者的动态血糖监测数据分别利用传统人工计算方法和本发明所述的计算方法计算得到的平均血糖波动幅度,共分3组,其中,正常成人27例,2型糖尿病成人患者25例,正常孕妇24例,MAGEO表示采用传统人工计算方法计算所得平均血糖波动幅,MAGEC表示采用本发明所述的计算方法计算所得平均血糖波动幅度。由于采用传统人工计算方法所得计算结果的准确性会受医务工作者的主观性影响,因此本表中MAGEO数值均为长期从事相关工作的工作人员采用传统人工计算方法获得,具有较高的准确性。The following table 1 shows the average blood sugar fluctuation range calculated from the continuous blood glucose monitoring data of 76 cases of medical patients by using the traditional manual calculation method and the calculation method of the present invention respectively, and is divided into 3 groups, of which 27 normal adults, 25 adult patients with type 2 diabetes and 24 normal pregnant women. MAGE O represents the average blood sugar fluctuation range calculated by traditional manual calculation method, and MAGE C represents the average blood sugar fluctuation range calculated by the calculation method of the present invention. Since the accuracy of calculation results obtained by traditional manual calculation methods will be affected by the subjectivity of medical workers, the values of MAGE O in this table are all obtained by traditional manual calculation methods by staff who have been engaged in relevant work for a long time, and have high accuracy. sex.

现将表1中3组的本发明所述的计算方法所得计算结果与传统人工计算方法所得计算结果进行相关性分析,分析结果如图5所示,正常成人组的相关系数γ=0.994(P<0.01),参见图5a),2型糖尿病成人患者组的相关系数γ=0.997(P<0.01),参见图5b),正常孕妇组的相关系数γ=0.998(P<0.01),参见图5c),76例就医者的相关系数γ=0.997(P<0.01),参见图5d),由此可知,本发明所述的计算方法所得计算结果MAGEC和传统人工计算方法所得计算结果MAGEO对于不同就医者分组均显著相关。Now carry out correlation analysis with the calculation result obtained by the calculation method of the present invention of 3 groups in table 1 and the calculation result obtained by traditional manual calculation method, the analysis result is as shown in Figure 5, and the correlation coefficient γ=0.994(P of normal adult group) <0.01), see Figure 5a), the correlation coefficient γ=0.997 (P<0.01), see Figure 5b) of type 2 diabetes adult group, the correlation coefficient γ=0.998 (P<0.01), see Figure 5c ), the correlation coefficient γ=0.997 (P<0.01) for 76 cases of medical patients, see Figure 5d), it can be seen that the calculation result MAGE C obtained by the calculation method of the present invention and the calculation result MAGE O obtained by the traditional manual calculation method are relatively There were significant correlations among different groups of medical seekers.

再通过Bland-Altman图评估本发明所述的计算方法和传统人工计算方法的一致性,所得结果如图6所示,不同就医者采用两种不同方法所得计算结果的差值分别为,正常成人组(-0.00242±0.0136)mmol*L-1,2型糖尿病成人患者组(0.01533±0.0275)mmol*L-1,正常孕妇组(0.0034±0.0191)mmol*L-1,76例就医者(0.00526±0.0218)mmol*L-1。95%一致性界限利用mean±1.96SD公式求得,分别为正常成人组(0.0243,-0.0292);2型糖尿病成人患者组(0.0692,-0.0386);正常孕妇组(0.0409,-0.0341);76例就医者(0.0480,-0.0374)。分析图6中不同的Bland-Altman图可知,落在一致性界限外的点分别为正常成人组3个,占11.1%(3/27);2型糖尿病成人患者组1个,占4%(1/25);正常孕妇组1个,占4.2%(1/24);76例就医者6个,占7.9%(6/76)。分析结果显示本发明所述的平均血糖波动幅度计算方法(MAGEc)与传统人工计算方法(MAGEo)具有较好的一致性。Evaluate the consistency of the calculation method of the present invention and the traditional artificial calculation method by Bland-Altman figure again, the obtained result is as shown in Figure 6, and the difference of the calculation result obtained by two kinds of different methods for different seekers is respectively, normal adult group (-0.00242±0.0136) mmol*L-1, adult patients with type 2 diabetes (0.01533±0.0275) mmol*L-1, normal pregnant women group (0.0034±0.0191) mmol*L-1, 76 patients (0.00526 ±0.0218) mmol*L-1. The limit of 95% agreement was obtained by mean±1.96SD formula, which were normal adult group (0.0243, -0.0292); type 2 diabetic adult patient group (0.0692, -0.0386); normal pregnant woman group (0.0409, -0.0341); 76 cases of medical treatment (0.0480, -0.0374). Analyzing the different Bland-Altman diagrams in Figure 6, it can be seen that there are 3 points falling outside the consistency limit in the normal adult group, accounting for 11.1% (3/27); 1 point in the type 2 diabetic adult group, accounting for 4% ( 1/25); 1 in the normal pregnant group, accounting for 4.2% (1/24); 6 of the 76 cases of medical treatment, accounting for 7.9% (6/76). The analysis results show that the calculation method (MAGEc) of the present invention has a good consistency with the traditional manual calculation method (MAGEo).

表1本发明所述计算方法与传统人工计算方法数据对比Table 1 Calculation method of the present invention and traditional manual calculation method data comparison

Figure BDA00002104964000071
Figure BDA00002104964000071

Claims (2)

1. the computing method of a MAGE, this method may further comprise the steps:
1) reads in the dynamic glucose monitor data that from dynamic blood sugar monitoring instrument device, obtains, calculate the blood sugar standard deviation of the data of being obtained; Calculate the extreme point all in the data that obtains, obtain the set A of an extreme point sequence;
2) utilize differential evolution algorithm to find the solution the objective function shown in the following formula (1), meet the extreme point of following two conditions in the statistics set A, obtain set B:
Absolute value >=blood sugar the standard deviation of the blood sugar value difference that two a. adjacent extreme points are corresponding;
B. one adjacent of two extreme point are maximum value, and another is a minimal value;
arg max K , n 1 , n 2 , . . . , n K Z K ( n 1 , n 2 , . . . , n K ) = arg max K , n 1 , n 2 , . . . , n K &Sigma; k = 1 K - 1 | f ( t n k + 1 ) - f ( t n k ) | - - - ( 1 )
In the formula (1), element n 1, n 2..., n kBe the element in the set A, Z K(n 1, n 2..., n k) be by element n 1, n 2..., n kSubclass { the n that is formed 1, n 2..., n kThe fluctuating range sum of corresponding effective blood glucose fluctuation, constant K is to satisfy the number of the extreme point of above-mentioned condition,
Figure FDA00002104963900012
Be subclass { n 1, n 2..., n kMiddle n kCorresponding blood glucose value;
The absolute value of the blood sugar value difference that 3) each adjacent extreme point is corresponding among the first set of computations B calculates all average absolute again, promptly gets MAGE.
2. the computing method of a kind of MAGE according to claim 1 is characterized in that, wherein step 1) also comprises following data pre-treatment step:
After reading in the dynamic glucose monitor data that from dynamic blood sugar monitoring instrument device, obtains, earlier the back blood glucose value data in the deletion blood glucose value equate adjacent 2 are calculated described blood sugar standard deviation and all extreme points again.
CN2012103278556A 2012-09-06 2012-09-06 Mean amplitude of glucose excursions (MAGE) calculation method Pending CN102831326A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012103278556A CN102831326A (en) 2012-09-06 2012-09-06 Mean amplitude of glucose excursions (MAGE) calculation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012103278556A CN102831326A (en) 2012-09-06 2012-09-06 Mean amplitude of glucose excursions (MAGE) calculation method

Publications (1)

Publication Number Publication Date
CN102831326A true CN102831326A (en) 2012-12-19

Family

ID=47334459

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012103278556A Pending CN102831326A (en) 2012-09-06 2012-09-06 Mean amplitude of glucose excursions (MAGE) calculation method

Country Status (1)

Country Link
CN (1) CN102831326A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109820522A (en) * 2019-01-22 2019-05-31 苏州乐轩科技有限公司 Mood arrangement for detecting, system and method
CN111110249A (en) * 2019-12-27 2020-05-08 中国科学院深圳先进技术研究院 Blood glucose fluctuation evaluation method and evaluation device
CN111419177A (en) * 2020-04-13 2020-07-17 复旦大学附属眼耳鼻喉科医院 Method and system for evaluating intraocular pressure fluctuation index during daytime
CN113447655A (en) * 2021-07-06 2021-09-28 北京大学国际医院 Blood glucose index combination for judging CPAP treatment effect
CN114530228A (en) * 2022-01-28 2022-05-24 广东工业大学 Blood glucose prediction method and system based on smoothing and fusion and medical equipment
CN118471435A (en) * 2024-07-10 2024-08-09 中国人民解放军总医院第二医学中心 Physical condition monitoring method, device and system for elderly patients in perioperative period

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001091633A1 (en) * 2000-05-30 2001-12-06 Instrumentation Metrics, Inc. A formula to manipulate blood glucose via the calculated ingestion of carbohydrate
CN101278847A (en) * 2006-12-21 2008-10-08 弗吉尼亚大学专利基金会 Systems, methods for self-monitoring of hyper/hypoglycemia, glucose variability and ineffectiveness

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001091633A1 (en) * 2000-05-30 2001-12-06 Instrumentation Metrics, Inc. A formula to manipulate blood glucose via the calculated ingestion of carbohydrate
CN101278847A (en) * 2006-12-21 2008-10-08 弗吉尼亚大学专利基金会 Systems, methods for self-monitoring of hyper/hypoglycemia, glucose variability and ineffectiveness

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GERT FRITZSCHE,ET AL.: "the use of a computer program to calculate the mean amplitude of glycemic excursions", 《DIABETES TECHNOLOGY & THERAPEUTICS》, vol. 13, no. 3, 31 December 2011 (2011-12-31) *
PETER A.BAGHURST,ET AL: "Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm", 《DIABETES TECHNOLOGY & THERAPEUTCIS》, vol. 13, no. 3, 31 December 2011 (2011-12-31) *
周健等: "应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度", 《中华内分泌代谢》, vol. 22, no. 3, 30 June 2006 (2006-06-30) *
李强等: "血糖波动的意义及临床评估方法", 《CHINESE JOURNAL OF PRACTICAL INTERNAL MEDICINE》, vol. 29, no. 9, 30 September 2009 (2009-09-30) *
简峻等: "平均血糖波动幅度计算机辅助计算算法及实现", 《中国生物医学工程学报》, vol. 30, no. 6, 31 December 2011 (2011-12-31), pages 820 - 828 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109820522A (en) * 2019-01-22 2019-05-31 苏州乐轩科技有限公司 Mood arrangement for detecting, system and method
CN111110249A (en) * 2019-12-27 2020-05-08 中国科学院深圳先进技术研究院 Blood glucose fluctuation evaluation method and evaluation device
CN111419177A (en) * 2020-04-13 2020-07-17 复旦大学附属眼耳鼻喉科医院 Method and system for evaluating intraocular pressure fluctuation index during daytime
CN113447655A (en) * 2021-07-06 2021-09-28 北京大学国际医院 Blood glucose index combination for judging CPAP treatment effect
CN114530228A (en) * 2022-01-28 2022-05-24 广东工业大学 Blood glucose prediction method and system based on smoothing and fusion and medical equipment
CN114530228B (en) * 2022-01-28 2022-09-27 广东工业大学 Blood glucose prediction method, system and medical device based on smoothing and fusion
CN118471435A (en) * 2024-07-10 2024-08-09 中国人民解放军总医院第二医学中心 Physical condition monitoring method, device and system for elderly patients in perioperative period
CN118471435B (en) * 2024-07-10 2024-09-17 中国人民解放军总医院第二医学中心 Physical condition monitoring method, device and system for elderly patients in perioperative period

Similar Documents

Publication Publication Date Title
CN117609813B (en) Intelligent management method for intensive patient monitoring data
CN102831326A (en) Mean amplitude of glucose excursions (MAGE) calculation method
Lee et al. Analysis of pulse arrival time as an indicator of blood pressure in a large surgical biosignal database: Recommendations for developing ubiquitous blood pressure monitoring methods
Rogers et al. Influence of artefact correction and recording device type on the practical application of a non-linear heart rate variability biomarker for aerobic threshold determination
Ciołek et al. Automated detection of sleep apnea and hypopnea events based on robust airflow envelope tracking in the presence of breathing artifacts
CN107203700B (en) Method and device based on continuous blood glucose monitoring
CN105249964B (en) Appraisal procedure is rebuild based on magneticencephalogram and the multi-modal brain function of diffusion tensor
CN109276241A (en) A kind of Pressure identification method and apparatus
CN110739076A (en) medical artificial intelligence public training platform
JP2019509101A (en) System and method for determining a hemodynamic instability risk score for pediatric subjects
CN104095635A (en) Method for calculating apparent diffusion coefficient of magnetic resonance images by utilizing autoregressive model
Lim et al. Improved measurement of blood pressure by extraction of characteristic features from the cuff oscillometric waveform
Yücelbaş et al. Pre-determination of OSA degree using morphological features of the ECG signal
Mora et al. Detection and analysis of heartbeats in seismocardiogram signals
Liu et al. Refined generalized multiscale entropy analysis for physiological signals
Siyahjani et al. Performance evaluation of a smart bed technology against polysomnography
CN111588353A (en) Body temperature measuring method
Cajal et al. Effects of missing data on heart rate variability metrics
CN117789999B (en) Medical health big data optimization acquisition method
Pourbabaee et al. SleepNet: automated sleep analysis via dense convolutional neural network using physiological time series
CN114266729A (en) A method and system for predicting radiation pneumonitis after radiotherapy for thoracic tumors based on machine learning
Cleatus et al. Epileptic seizure detection using spectral transformation and convolutional neural networks
CN116019429A (en) Health monitoring method, device, equipment and storage medium based on physiological index
Bajić et al. On quantization errors in approximate and sample entropy
CN118762851B (en) An intelligent analysis method of medical records of pulmonary tuberculosis patients for early warning of hemoptysis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121219